Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Female Reproductive System Adenocarcinoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Epithelial Neoplasm
Glandular Cell Neoplasm
Adenocarcinoma
Female Reproductive System Adenocarcinoma

Subtype

Female Reproductive System Adenocarcinoma

CI-CAN-00002684Explore in graph →

158 active trials1 approved drugs15 evidence items

NCIt: C215409

Overview
Statistics
Survival
Genomics10
Variants & evidence15
Drugs11
Trials454
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

454 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 158
Recruiting: 74
Ph III recruiting: 10
Growth YoY: +19%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (59)

StatusAll Active (any)Completed 169 Recruiting 93 Active Not Recruiting 69 Terminated 46 Unknown 30 Not Yet Recruiting 25 Withdrawn 20 Suspended 1 No Longer Available 1

PhaseAll Early Phase 1 14 N/A 42 Phase 1 122 Phase 2 197 Phase 3 52

No study matches these filters